I agree that this site is using cookies. You can find further informations here.
X
Armstrong, DK
834  results:
Search for persons X
?
1

The role of nonrandomized trials in the evaluation of oncol..:

Simon, R ; Blumenthal, GM ; Rothenberg, ML...
Clinical Pharmacology & Therapeutics.  97 (2015)  5 - p. 502-507 , 2015
Link: https://doi.org/10.1002/..
 
?
2

Taxol: A unique antineoplastic agent with significant activ..:

McGuire, WP ; Rowinsky, EK ; Rosenhein, NB...
International Journal of Gynecology & Obstetrics.  31 (1990)  3 - p. 298-298 , 1990
Link: https://doi.org/10.1016/..
 
?
3

Rucaparib maintenance treatment for recurrent ovarian carci..:

Clamp, AR ; Lorusso, D ; Oza, AM...
https://discovery.ucl.ac.uk/id/eprint/10130249/3/Ledermann_ARIEL3_Clamp%20Lorusso_Prior%20therapies%20PFI_Draft_12Apr_main%20document.pdf.  , 2021
Link: https://discovery.ucl.ac..
 
?
4

Maintenance treatment with rucaparib for recurrent ovarian ..:

Oaknin, A ; Oza, AM ; Lorusso, D...
Cancer medicine, 2021, 10 (20), pp. 7162 - 7173.  , 2021
Link: https://repository.icr.a..
 
?
5

Maintenance treatment with rucaparib for recurrent ovarian ..:

Oaknin, A ; Oza, AM ; Lorusso, D...
https://discovery.ucl.ac.uk/id/eprint/10135859/1/Ledermann_Maintenance%20treatment%20with%20rucaparib%20for%20recurrent%20ovarian%20carcinoma%20in%20ARIEL3,%20a%20randomized%20phase%203%20trial_AOP.pdf.  , 2021
Link: https://discovery.ucl.ac..
 
?
6

Rucaparib for patients with platinum-sensitive, recurrent o..:

Ledermann, JA ; Oza, AM ; Lorusso, D...
https://discovery.ucl.ac.uk/id/eprint/10102611/1/PDFproof_13JAN20c.pdf.  , 2020
Link: https://discovery.ucl.ac..
 
?
7

The effect of age on efficacy, safety and patient-centered ..:

Colombo, N ; Oza, AM ; Lorusso, D...
https://discovery.ucl.ac.uk/id/eprint/10109791/9/Ledermann_1-s2.0-S0090825820311306-main.pdf.  , 2020
Link: https://discovery.ucl.ac..
 
?
8

Patient-Centered Outcomes in ARIEL3, a Phase III, Randomize..:

Oza, AM ; Lorusso, D ; Aghajanian, C...
https://discovery.ucl.ac.uk/id/eprint/10109518/1/jco.19.03107.pdf.  , 2020
Link: https://discovery.ucl.ac..
 
?
9

A Randomized Phase II Trial of Epigenetic Priming with Guad..:

Oza, AM ; Matulonis, UA ; Alvarez Secord, A...
https://discovery.ucl.ac.uk/id/eprint/10092744/1/Guadecitabine%20and%20carboplatin%20in%20ovarian%20cancer.pdf.  , 2020
Link: https://discovery.ucl.ac..
 
?
10

A randomised, double-blind, placebo-controlled trial of rep..:

Alton, EWFW ; Armstrong, DK ; Ashby, D...
doi:10.3310/eme03050.  , 2019
Link: https://doi.org/10.3310/..
 
?
11

OV21/PETROC: a randomized Gynecologic Cancer Intergroup pha..:

Provencher, DM ; Gallagher, CJ ; Parulekar, WR...
https://discovery.ucl.ac.uk/id/eprint/10051632/1/Ledermann_Nov%2010%20CLEAN%20OV21%20Annals%20of%20Oncology%20Submission.pdf.  , 2018
Link: https://discovery.ucl.ac..
 
?
12

Rucaparib maintenance treatment for recurrent ovarian carci..:

Coleman, RL ; Oza, AM ; Lorusso, D...
https://discovery.ucl.ac.uk/id/eprint/1575415/1/_ARIEL3_CollatedSub_THELANCET-D-17-05358R1.pdf.  , 2017
Link: https://discovery.ucl.ac..
 
?
13

Rucaparib maintenance treatment for recurrent ovarian carci..:

Coleman, RL ; Oza, AM ; Lorusso, D...
Lancet.  , 2017
Link: http://hdl.handle.net/10..
 
?
14

Repeated nebulisation of non-viral CFTR gene therapy in pat..:

Alton, EWFW ; Armstrong, DK ; Ashby, D...
doi:10.1016/s2213-2600(15)00245-3.  , 2016
Link: https://doi.org/10.1016/..
 
?
15

A randomised, double-blind, placebo-controlled trial of rep..:

Alton, EW ; Armstrong, DK ; Ashby, D...
https://discovery.ucl.ac.uk/id/eprint/10045604/1/Efficacy%20and%20Mechanism%20Evaluation%20CF.pdf.  , 2016
Link: https://discovery.ucl.ac..
 
1-15